Retrospective assessment of rat liver microsomal stability at NCATS: data and QSAR models.
Animals
Computer Simulation
Databases, Factual
Drug Discovery
/ methods
High-Throughput Screening Assays
/ methods
Liver
/ metabolism
Machine Learning
Male
Microsomes, Liver
/ metabolism
National Center for Advancing Translational Sciences (U.S.)
Pharmaceutical Preparations
/ metabolism
Quantitative Structure-Activity Relationship
Rats
Rats, Sprague-Dawley
Retrospective Studies
United States
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
26 11 2020
26 11 2020
Historique:
received:
06
08
2020
accepted:
04
11
2020
entrez:
27
11
2020
pubmed:
28
11
2020
medline:
16
3
2021
Statut:
epublish
Résumé
Hepatic metabolic stability is a key pharmacokinetic parameter in drug discovery. Metabolic stability is usually assessed in microsomal fractions and only the best compounds progress in the drug discovery process. A high-throughput single time point substrate depletion assay in rat liver microsomes (RLM) is employed at the National Center for Advancing Translational Sciences. Between 2012 and 2020, RLM stability data was generated for ~ 24,000 compounds from more than 250 projects that cover a wide range of pharmacological targets and cellular pathways. Although a crucial endpoint, little or no data exists in the public domain. In this study, computational models were developed for predicting RLM stability using different machine learning methods. In addition, a retrospective time-split validation was performed, and local models were built for projects that performed poorly with global models. Further analysis revealed inherent medicinal chemistry knowledge potentially useful to chemists in the pursuit of synthesizing metabolically stable compounds. In addition, we deposited experimental data for ~ 2500 compounds in the PubChem bioassay database (AID: 1508591). The global prediction models are made publicly accessible ( https://opendata.ncats.nih.gov/adme ). This is to the best of our knowledge, the first publicly available RLM prediction model built using high-quality data generated at a single laboratory.
Identifiants
pubmed: 33244000
doi: 10.1038/s41598-020-77327-0
pii: 10.1038/s41598-020-77327-0
pmc: PMC7693334
doi:
Substances chimiques
Pharmaceutical Preparations
0
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
20713Subventions
Organisme : NCI NIH HHS
ID : T32 CA078207
Pays : United States
Références
J Pharm Sci. 2010 Nov;99(11):4463-8
pubmed: 20845445
J Med Chem. 2000 Oct 19;43(21):3878-94
pubmed: 11052793
Eur J Drug Metab Pharmacokinet. 2004 Apr-Jun;29(2):133-43
pubmed: 15230342
J Med Chem. 2018 Jun 14;61(11):4883-4903
pubmed: 29767973
J Comput Aided Mol Des. 2010 Jan;24(1):23-35
pubmed: 19937264
J Chem Inf Model. 2016 Jul 25;56(7):1243-52
pubmed: 27280890
Acta Pharm. 2019 Sep 1;69(3):345-361
pubmed: 31259741
Mol Inform. 2018 Jan;37(1-2):
pubmed: 29095571
Mol Biotechnol. 2004 Jun;27(2):139-68
pubmed: 15208456
ACS Cent Sci. 2018 Jan 24;4(1):120-131
pubmed: 29392184
J Microbiol Methods. 2000 Dec 1;43(1):3-31
pubmed: 11084225
Future Med Chem. 2012 Oct;4(15):1933-44
pubmed: 23088274
J Mol Graph Model. 2008 Feb;26(6):907-15
pubmed: 17683964
ACS Pharmacol Transl Sci. 2020 Sep 11;3(5):948-964
pubmed: 33073193
Curr Opin Drug Discov Devel. 2010 Jan;13(1):78-85
pubmed: 20047148
J Chem Inf Model. 2012 Mar 26;52(3):792-803
pubmed: 22360769
Pharmacol Ther. 2013 Apr;138(1):103-41
pubmed: 23333322
Drug Discov Today. 1999 May;4(5):232-237
pubmed: 10322290
Nat Rev Drug Discov. 2004 Aug;3(8):711-5
pubmed: 15286737
Chem Res Toxicol. 2001 Jun;14(6):611-50
pubmed: 11409933
Future Med Chem. 2018 Jul 1;10(13):1575-1588
pubmed: 29953260
J Chem Inf Model. 2007 Jan-Feb;47(1):159-69
pubmed: 17238261
J Clin Pharmacol. 2009 May;49(5):513-33
pubmed: 19299532
J Chem Inf Model. 2010 Mar 22;50(3):339-48
pubmed: 20121045
Front Artif Intell. 2019 Sep 06;2:17
pubmed: 33733106
Neural Comput. 1997 Nov 15;9(8):1735-80
pubmed: 9377276
Methods Enzymol. 2002;357:285-95
pubmed: 12424918
Drug Metab Lett. 2016;10(2):83-90
pubmed: 26902079
Chem Sci. 2017 Oct 31;9(2):513-530
pubmed: 29629118
Mol Inform. 2011 Dec;30(11-12):960-72
pubmed: 27468151
J Med Chem. 2011 Nov 24;54(22):7739-50
pubmed: 21936582
J Chem Inf Model. 2019 Aug 26;59(8):3370-3388
pubmed: 31361484
J Chem Inf Model. 2015 Aug 24;55(8):1566-75
pubmed: 26170251
J Chem Inf Model. 2006 Sep-Oct;46(5):1924-36
pubmed: 16995723
J Med Chem. 2005 Nov 3;48(22):6970-9
pubmed: 16250655
Drug Metab Dispos. 2016 Oct;44(10):1653-61
pubmed: 27417180
Comput Struct Biotechnol J. 2016 Dec 13;15:86-90
pubmed: 28066532
J Chem Inf Model. 2013 Apr 22;53(4):783-90
pubmed: 23521722
J Cheminform. 2020 Apr 7;12(1):21
pubmed: 33431020
J Pharm Sci. 2009 Aug;98(8):2857-67
pubmed: 19116953
J Chem Inf Comput Sci. 2004 Jul-Aug;44(4):1477-88
pubmed: 15272856
J Chem Inf Model. 2010 May 24;50(5):742-54
pubmed: 20426451
J Pharm Sci. 2004 Jun;93(6):1537-44
pubmed: 15124211
IEEE Trans Neural Netw Learn Syst. 2017 Oct;28(10):2222-2232
pubmed: 27411231
J Chem Inf Comput Sci. 1998 May-Jun;38(3):511-22
pubmed: 9611787